This is a routine insider filing with no trading activity or material corporate event. Monitor for future Form 4 filings if Bain exercises or sells warrants, which could signal insider sentiment.
Price Chart
Executive Summary
Linda Catharina Bain filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing her holdings in Hemab Therapeutics Holdings, Inc. (COAG). The filing is a routine insider onboarding requirement and contains no material financial or operational information about the company.
Key Facts
- Linda Catharina Bain filed an initial statement of beneficial ownership (Form 3) on April 30, 2026.
- Bain holds three tranches of warrants to purchase common stock: 25,564 shares at $2.16 (expiring 2032-03-20), 20,328 shares at $7.07 (expiring 2033-08-13), and 19,448 shares at $6.00 (expiring 2036-01-28).
- The warrants were granted on March 21, 2022, August 14, 2023, and January 29, 2026, respectively, and are fully vested except for the most recent tranche which vests monthly through January 2029.
- A power of attorney was also filed authorizing designees to file future SEC reports on Bain's behalf.
Financial Impact
No financial impact; the filing discloses warrant holdings with no transaction or monetary value stated.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-198205 |
| Document: 0001193125-26-198205-index-headers.html | 0001193125-26-198205 |
| Document: 0001193125-26-198205-index.html | 0001193125-26-198205 |
| Document: 0001193125-26-198205.txt | 0001193125-26-198205 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | 8-K | $49.87 $44.50 | ▼ −10.77% | ▼ −9.71% | $30.36 (−39.12%) |
Jun 17, 2026 15w ago | Insider Buy | $29.24 $44.53 | ▲ +52.29% | ▲ +51.76% | $30.36 (+3.83%) |
May 21, 2026 19w ago | Press Release | $26.30 $31.83 | ▲ +21.03% | ▲ +20.69% | $30.36 (+15.44%) |
May 4, 2026 21w ago | 8-K | $25.00 $27.47 | ▲ +9.88% | ▲ +4.93% | $30.36 (+21.44%) |
Apr 30, 2026 22w ago | Press Release | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
Apr 30, 2026 22w ago | 3 | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
Apr 30, 2026 22w ago | 3 | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
Apr 30, 2026 22w ago | 3 | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
Apr 30, 2026 22w ago | 3 | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
Apr 30, 2026 22w ago | 3 | $34.00 $27.13 | ▼ −20.21% | ▼ −25.47% | $30.36 (−10.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access